Biotechnology stocks and exchange traded funds are into a second year of disappointing investors, but that condition won’t be permanent. With that in mind, investors evaluating ideas for a biotech resurgence may want to consider basic offerings, including the VanEck Vectors Biotech ETF (BBH). BBH...